Tradestie Institutional Equity Comparison Engine
BGM vs TLSA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BGM Overall Edge
BGM Captures Institutional Edge (1โ1 Pillars ยท 6โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to BGM Group Ltd. Class A Ordinary Shares (BGM) driven by superior Momentum & Technical while TLSA counters with relative strength in Growth & Margin. Fundamentally, BGM trades at N/M Forward P/E with -23.4% operating margin (+69.8% YoY revenue) versus TLSA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, BGM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against TLSA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
BGM N/M vs TLSA N/M Fwd P/E
Growth & Margin Winner
TLSA
Op Margin -23.4% vs 0.0% ยท YoY +69.8% vs +0.0%
Momentum & Technical Winner
BGM
1Y -17.5% vs -63.3% ยท 52W Pos 74% vs 5%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
BGM
NASDAQ
BGM Group Ltd. Class A Ordinary Shares
Pharmaceutical Preparations
$8.00
-1.6% 1D
Market Cap
$108.6M
1M Return
-21.57%
1Y Return
-17.53%
Forward P/E
N/M
Unified AI Score
59.6 / 100
HOLD
Tech 65.0
Fund 55.0
Flow 50.0
Mom 50.0
TLSA
NASDAQ
Tiziana Life Sciences Ltd. Common Shares
Pharmaceutical Preparations
$0.62
-8.14% 1D
Market Cap
$86.5M
1M Return
-37.94%
1Y Return
-63.28%
Forward P/E
N/M
Unified AI Score
50.9 / 100
HOLD
Tech 55.0
Fund 56.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BGM -17.53%
TLSA -63.28%
Spread: +54.25 pp (BGM Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
BGM TTM Op. Margin: -23.4%
TLSA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BGM vs TLSA. Trailing 12-month operating profitability (BGM -23.4% vs TLSA 0.0%) and valuation multiples (BGM N/M vs TLSA N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BGM | TLSA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $108.6M | $86.5M | Larger Scale | BGM |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +69.8% | +0.0% | Higher Growth | BGM |
| Operating Margin (TTM) Profitability | -23.4% | 0.0% | Higher Margin | TLSA |
| Net Profit Margin Profitability | -44.2% | 0.0% | Higher Margin | TLSA |
| Return on Equity (ROE) Capital Efficiency | -7.4% | -780.6% | Higher ROE | BGM |
| 52-Week Range Position Momentum | 74% ($0โ$11) | 5% ($1โ$2) | Stronger Trend | BGM |
| Beta / 30D Volatility Risk Regime | 3.69ฮฒ ยท 80% Vol | 1.10ฮฒ ยท 153% Vol | Lower Realized Risk | BGM |
| Unified Institutional Score Composite Signal | 59.6 / 100 (HOLD) | 50.9 / 100 (HOLD) | Higher Composite | BGM |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BGM vs TLSA Buy Guide
BGM
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
TLSA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BGM nor TLSA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.